Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
Active, not recruiting · NCT04289779 · Registry updated 2024-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, neoplasm, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Active, not recruiting | Phase 2 | 2024-12-04 | NCT04289779 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Deepak Kilari | 2 |
| Exelixis | 77 |
| Genentech, Inc. | 221 |
| Medical College of Wisconsin | 201 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Froedtert and The Medical College of Wisconsin | Milwaukee | United States | 21 |
| John Theurer Cancer Center | Hackensack | United States | 20 |
| University of Rochester Medical Center | Rochester | United States | 162 |
| Vanderbilt-Ingram Cancer Center | Nashville | United States | 48 |
| Virginia Commonwealth University | Richmond | United States | 156 |
| Washington University School of Medicine | St Louis | United States | 895 |